Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03972397 · ClinicalTrials.gov registry record · Phase 4
Intercostal Nerve Cryoablation for Postoperative Pain Management
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT03972397 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 20 participants.
The verdict
NCT03972397, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the efficacy of intercostal nerve cryoablation on the magnitude and duration of postoperative pain control both in patients undergoing thoracoabdominal incisions for the descending or thoracoabdominal aortic aneurysm repair.
Interventions
- DEVICE Intercostal Nerve Cryoablation
- DRUG Patient-controlled analgesia (PCA)
- DRUG Bupivacaine liposomal injectable suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-07-15 |
| Est. Completion | 2022-09-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03972397
The ClinicalTrials.gov registry entry for NCT03972397 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Intercostal Nerve Cryoablation is the first listed.
NCT03972397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03972397 about?
NCT03972397 is a clinical study titled "Intercostal Nerve Cryoablation for Postoperative Pain Management". The purpose of the study is to assess the efficacy of intercostal nerve cryoablation on the magnitude and duration of postoperative pain control both in patients undergoing thoracoabdominal incisions for the descending or thoracoabdominal aortic aneurysm repair.
What is the current status of trial NCT03972397?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2019-07-15. Estimated completion is 2022-09-22.
What interventions are being tested in trial NCT03972397?
The interventions under investigation include: Intercostal Nerve Cryoablation (DEVICE), Patient-controlled analgesia (PCA) (DRUG), Bupivacaine liposomal injectable suspension (DRUG).
Who is sponsoring clinical trial NCT03972397?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.